R&D Gravity is an experimental variable pharma has rarely been a... Microgravity should not be a destination for pharmaceutical R&D, but another experimental environment.
News UK's Levicept builds case for osteoarthritis therapy at ACR New data on Levicept's LEVI-04 in patients with osteoarthritis support its potential to become the first new systemic treatment in over two decades.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.
